Cytokinetics (CYTK) PT Raised to $19 at Cowen
Tweet Send to a Friend
Cowen raised its price target on Cytokinetics (NASDAQ: CYTK) to $19.00 (from $17.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
